US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
EP2266564B1
(en)
|
1997-12-22 |
2013-03-13 |
Euro-Celtique S.A. |
Pharmaceutical oral dosage form comprising a combination of an opioid agonist and an opioid antagonist
|
EP1387673B1
(en)
|
2001-05-11 |
2010-12-29 |
Endo Pharmaceuticals Inc. |
Abuse-resistant controlled-release opioid dosage form
|
EP1414458B1
(en)
|
2001-07-06 |
2007-04-11 |
Endo Pharmaceuticals Inc. |
Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
NZ535286A
(en)
|
2002-04-05 |
2007-07-27 |
Euro Celtique Sa |
Matrix for sustained, invariant and independent release of active compounds
|
PT1492511E
(pt)
|
2002-04-09 |
2009-04-09 |
Flamel Tech Sa |
Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
|
DE10250083A1
(de)
*
|
2002-06-17 |
2003-12-24 |
Gruenenthal Gmbh |
Gegen Missbrauch gesicherte Darreichungsform
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
CA2499550C
(en)
*
|
2002-09-20 |
2013-10-15 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
DE10250084A1
(de)
*
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
ES2350689T3
(es)
|
2002-12-13 |
2011-01-26 |
Durect Corporation |
Sistema de suministro de fármacos oral que comprende materiales vehículo líquidos de alta viscosidad.
|
EP1782834A3
(en)
*
|
2003-03-13 |
2007-08-01 |
Controlled Chemicals, Inc. |
Oxycodone conjugates with lower abuse potential and extended duration of action
|
US8906413B2
(en)
*
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
EP2112920B1
(en)
|
2003-06-26 |
2018-07-25 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
PE20050728A1
(es)
*
|
2003-08-06 |
2005-11-10 |
Gruenenthal Chemie |
Forma de dosificacion a prueba de abuso
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
EP1677768A4
(en)
*
|
2003-10-03 |
2011-06-29 |
Elite Lab Inc |
PROLONGED RELEASE OPIOID FORMULATIONS AND METHOD OF USING THE FORMULATIONS
|
US20050163718A1
(en)
*
|
2004-01-23 |
2005-07-28 |
Shugart Jack I. |
Injectable euthanasia compositions that include a taste aversive agent
|
GB0501638D0
(en)
*
|
2005-01-28 |
2005-03-02 |
Euro Celtique Sa |
Particulates
|
DE102004019916A1
(de)
*
|
2004-04-21 |
2005-11-17 |
Grünenthal GmbH |
Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
ITMI20041317A1
(it)
*
|
2004-06-30 |
2004-09-30 |
Ibsa Inst Biochimique Sa |
Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
FR2878161B1
(fr)
*
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
EA015615B1
(ru)
*
|
2005-01-28 |
2011-10-31 |
Еуро-Селтик С.А. |
Устойчивые к спиртам лекарственные формы
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
FR2889810A1
(fr)
*
|
2005-05-24 |
2007-02-23 |
Flamel Technologies Sa |
Forme medicamenteuse orale, microparticulaire, anti-mesurage
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
FR2892937B1
(fr)
*
|
2005-11-10 |
2013-04-05 |
Flamel Tech Sa |
Forme pharmaceutique orale microparticulaire anti-mesusage
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
JP5457830B2
(ja)
|
2006-04-03 |
2014-04-02 |
オディディ,イサ |
オルガノゾル被膜を含む制御放出送達デバイス
|
US10960077B2
(en)
*
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US9023400B2
(en)
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
FR2901478B1
(fr)
*
|
2006-05-24 |
2015-06-05 |
Flamel Tech Sa |
Forme pharmaceutique orale multimicroparticulaire a liberation prolongee
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US8093261B2
(en)
|
2006-10-24 |
2012-01-10 |
The Johns Hopkins University |
Rapid release mini-tablets provide analgesia in laboratory animals
|
JP2011506318A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
経口医薬製剤
|
RU2010129907A
(ru)
|
2007-12-17 |
2012-01-27 |
Лабофарм Инк. (CA) |
Лекарственная форма с контролируемым высвобождением, предотвращающая неправильное употребление
|
JP5774853B2
(ja)
|
2008-01-25 |
2015-09-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
医薬投薬形
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
TWI524904B
(zh)
|
2008-05-09 |
2016-03-11 |
歌林達股份有限公司 |
製備醫藥用固體劑型,尤指錠劑之方法,及製備固體劑型,尤指錠劑之前驅物之方法
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
JP5667575B2
(ja)
|
2008-12-16 |
2015-02-12 |
パラディン ラブス インコーポレーテッド |
誤用を防止する放出制御製剤
|
TR201900199T4
(tr)
|
2009-03-10 |
2019-02-21 |
Euro Celtique Sa |
Oksikodon ve nalokson içeren çabuk salımlı farmasötik bileşimler.
|
CA2765971C
(en)
|
2009-07-22 |
2017-08-22 |
Gruenenthal Gmbh |
Hot-melt extruded controlled release dosage form
|
JP2012533586A
(ja)
|
2009-07-22 |
2012-12-27 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
酸化安定化された不正使用防止剤形
|
AU2011297901B2
(en)
|
2010-09-02 |
2014-07-31 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
NZ608865A
(en)
|
2010-09-02 |
2015-03-27 |
Gruenenthal Chemie |
Tamper resistant dosage form comprising an anionic polymer
|
CA2827273A1
(en)
*
|
2011-02-17 |
2012-08-23 |
QRxPharma Ltd. |
Technology for preventing abuse of solid dosage forms
|
PT2736497T
(pt)
|
2011-07-29 |
2017-11-30 |
Gruenenthal Gmbh |
Comprimido resistente a adulteração proporcionando libertação imediata de fármaco
|
CN103841964A
(zh)
|
2011-07-29 |
2014-06-04 |
格吕伦塔尔有限公司 |
提供药物立即释放的抗破碎片剂
|
AU2012310250B2
(en)
*
|
2011-09-16 |
2016-03-03 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
FR2983409B1
(fr)
*
|
2011-12-06 |
2013-12-27 |
Ethypharm Sa |
Comprime susceptible de lutter contre le detournement par voie injectable
|
GB201202433D0
(en)
*
|
2012-02-13 |
2012-03-28 |
Diurnal Ltd |
Controlled drug release
|
JP6117249B2
(ja)
|
2012-02-28 |
2017-04-19 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
|
NZ629468A
(en)
*
|
2012-03-02 |
2017-08-25 |
Rhodes Pharmaceuticals Lp |
Tamper resistant immediate release formulations
|
KR101701013B1
(ko)
*
|
2012-03-02 |
2017-01-31 |
로도스 파머시티컬스 엘.피. |
부정조작 방지 즉각 방출 제형
|
WO2013156453A1
(en)
|
2012-04-18 |
2013-10-24 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
MX2014015880A
(es)
*
|
2012-07-06 |
2015-08-05 |
Egalet Ltd |
Composiciones farmaceuticas disuasivas de abuso para liberacion controlada.
|
US9149533B2
(en)
*
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US10420729B2
(en)
*
|
2013-03-15 |
2019-09-24 |
R.P. Scherer Technologies, Llc |
Abuse resistant capsule
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
CA2913209A1
(en)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Tamper resistant dosage form with bimodal release profile
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
MX368846B
(es)
|
2013-07-12 |
2019-10-18 |
Gruenenthal Gmbh |
Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
|
MY183489A
(en)
|
2013-07-23 |
2021-02-22 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
EP3073994A1
(en)
|
2013-11-26 |
2016-10-05 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
JP6336078B2
(ja)
*
|
2013-12-03 |
2018-06-06 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
医薬組成物
|
EP3142646A1
(en)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
EA201692388A1
(ru)
|
2014-05-26 |
2017-05-31 |
Грюненталь Гмбх |
Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
|
EA035434B1
(ru)
|
2015-04-24 |
2020-06-15 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
|
EP3346991A1
(en)
|
2015-09-10 |
2018-07-18 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
EP3473246A1
(en)
|
2017-10-19 |
2019-04-24 |
Capsugel Belgium NV |
Immediate release abuse deterrent formulations
|
JP2022527690A
(ja)
*
|
2019-03-11 |
2022-06-03 |
ノシオン セラピューティクス,インコーポレイテッド |
荷電したイオンチャンネル遮断薬および使用方法
|